Has Christopher Marrocco, MD received payments from drug or device companies?

Yes. Drug and device makers reported $81,117 in general payments to Christopher Marrocco, MD across 215 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Marrocco, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Marrocco, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Marrocco, MD

Vascular Surgery · Lynwood, CANPI 1124208459

Payments from drug & device makers

What this record shows

This record is dominated by other: $60,000 of the $81,117 with a category attached, or 74.0%. Angiodynamics, Inc. accounts for 92.2% of it on its own, with 29 other manufacturers making up the rest. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,117in general payments, 2019–2025

Across 215 payments — averaging $377.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$75K
Organogenesis Inc.$2K
Endologix LLC$927
Medtronic$671
Philips North America LLC$398
Boston Scientific$390
plus $2K from 24 others

$50,000in ownership & investment interests, 2019–2025

Across 3 payments — averaging $16,667 each. An ownership or investment interest held by the physician or an immediate family member.

Vasorum USA Inc.$50K

What the payments were for

Travel & lodging$460%
Food & beverage$7,1549%
Education$13,91717%
Other$60,00074%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	30	$74,795
Organogenesis Inc.	61	$2,023
Endologix LLC	6	$927
Medtronic(2 entities)	22	$671
Philips North America LLC	20	$398
Boston Scientific	15	$390
Koya Medical, Inc.	1	$385
Shockwave Medical, Inc	8	$244
Lemaitre Vascular, Inc.	8	$205
Bard Peripheral Vascular, Inc.	8	$154
Terumo Medical Corporation	6	$140
Cardiovascular Systems Inc.	6	$105
Penumbra, Inc.	1	$103
Inari Medical, Inc.	2	$75
Cook Medical LLC	2	$54
Venclose Inc.	2	$47
W. L. Gore & Associates, Inc.	2	$43
Smith+Nephew	2	$34
Getinge USA Sales, LLC	1	$32
Johnson & Johnson	2	$31
Cvrx, Inc.	1	$31
Acell, Inc.	1	$30
Cardiva Medical, Inc.	1	$29
Merit Medical Systems Inc	1	$27
Pfizer	1	$27
Abbott	1	$26
Acera Surgical, Inc.	1	$25
BD	1	$24
Biotronik Inc.	1	$23
Ascensia Diabetes Care US Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,117 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024

$1,150,573

Medicare patients

240

Services billed

1,964

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Lynwood

Son DuongFountain Valley$503K
Venita ChandraPalo Alto$488K
Sukgu HanLos Angeles$477K
Leigh Ann ObanionFresno$469K
Trevor DerderianRancho Mirage$359K
Karthikeshwar KasirajanPalo Alto$349K
Johnathon RolloLos Angeles$337K
Melissa LojaFairfield$272K
Jason LeePalo Alto$228K
John LaneSan Diego$212K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →